Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Cancer Immunol Immunother ; 72(12): 4195-4207, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-37848682

RESUMO

T cells expressing a mesothelin (MSLN)-specific T cell receptor fusion construct (TRuC®), called TC-210, have demonstrated robust antitumor activity in preclinical models of mesothelioma, ovarian cancer, and lung cancer. However, they are susceptible to suppression by the programmed cell death protein 1 (PD-1)/programmed cell death protein ligand 1 (PD-L1) axis and lack intrinsic costimulatory signaling elements. To enhance the function of anti-MSLN TRuC-T cells, chimeric switch receptors (CSRs) have been designed to co-opt the immunosuppressive PD-1/PD-L1 axis and to deliver a CD28-mediated costimulatory signal. Here, we report that coexpression of the PD1-CD28 CSR in TRuC-T cells enhanced T cell receptor signaling, increased proinflammatory effector cytokines, decreased anti-inflammatory cytokines, and sustained effector function in the presence of PD-L1 when compared with TC-210. Anti-MSLN TRuC-T cells engineered to coexpress PD1-CD28 CSRs comprising the ectodomain of PD-1 and the intracellular domain of CD28 linked by the transmembrane domain of PD-1 were selected for integration into an anti-MSLN TRuC-T cell therapy product called TC-510. In vitro, TC-510 showed significant improvements in persistence and resistance to exhaustion upon chronic stimulation by tumor cells expressing MSLN and PD-L1 when compared with TC-210. In vivo, TC-510 showed a superior ability to provide durable protection following tumor rechallenge, versus TC-210. These data demonstrate that integration of a PD1-CD28 CSR into TRuC-T cells improves effector function, resistance to exhaustion, and prolongs persistence. Based on these findings, TC-510 is currently being evaluated in patients with MSLN-expressing solid tumors.


Assuntos
Antígenos CD28 , Mesotelioma , Humanos , Mesotelina , Receptor de Morte Celular Programada 1/metabolismo , Antígeno B7-H1/genética , Antígeno B7-H1/metabolismo , Linfócitos T/metabolismo , Receptores de Antígenos de Linfócitos T/metabolismo , Citocinas/metabolismo
2.
Prof Nurse ; 17(10): 612-5, 2002 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12087711

RESUMO

The majority of teenage mothers in the UK come from poor backgrounds, with few prospects of work locally and little to aim for educationally. But with help from government education and child-care schemes and the intervention of health-care professionals, much can be done to improve their position. This paper looks at current research and practical projects in this area.


Assuntos
Gravidez na Adolescência/psicologia , Isolamento Social , Adolescente , Serviços de Saúde do Adolescente , Serviços de Planejamento Familiar , Feminino , Humanos , Serviços de Saúde Materna/estatística & dados numéricos , Gravidez , Apoio Social , Medicina Estatal , Reino Unido
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA